Search results
Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally. As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland.
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company , Roche Holding AG , has shares listed on the SIX Swiss Exchange .
Four-plex test for SARS-CoV-2, Influenza A/B and RSV receives FDA Emergency Use Authorization. Now, HCPs will be able to detect and differentiate these respiratory viruses within a single patient visit, enabling improved public health outcomes.
About Roche. Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.
Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives.
Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases.
Innovation across the Roche Group. Our close strategic partnerships across the Group, and our diverse mix of autonomous innovation engines gives us a rich diversity of expertise and scientific thinking, as we seek to discover and develop solutions to the biggest questions in healthcare today.
Discover how Roche made an impact in 2023 Discover our innovative journey in revolutionising patient care and how we’ve impacted millions worldwide. Explore our Annual Report to see our strides in pharmaceuticals and diagnostics.
As a global leader in healthcare, we are one of the world’s largest biotech companies and the leading supplier of in-vitro diagnostics. We’re an innovator across major disease areas, including oncology, neurology, infectious diseases, and ophthalmology.
Roche announced today that its whole slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the FDA. The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose patients.
